In the SUSTAIN program trials, gastrointestinal adverse events were the most common reason for discontinuation, with nausea, vomiting, diarrhea, and belching all linked mechanistically to this delayed transit
Tirzepatide Dose Progression and Weight Loss Acceleration Tirzepatide dosing follows a proven titration ladder: starting doses are usually 2.5 mg weekly, then increasing to 5 mg, 7.5 mg, 10 mg, and potentially higher based on clinical response and side-effect tolerance
This is where targeted nutritional support becomes a vital piece of the management puzzle
A 0.5mg vial is the better choice it yields 10 doses (0.5mg = 500mcg 50mcg = 10), lasting exactly 5 weeks at twice-weekly dosing, well within the refrigerated stability window and minimizing waste
Twitter and society